Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
US8440189B2 · kind B2 · utility
3Cited by
35References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 30, 2011 |
| Grant date | May 14, 2013 |
| Priority date | — |
| Expiry date | Jun 30, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to reagents which modify the activity of TWEAK and their use as therapeutic agents for the treatment of immunological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.